Annual report
7776.TEDINET S100QIL1
Period2022-01-01 → 2022-12-31
Filed2023-03-31
StandardJapan GAAP
ConsolidatedNo
Data checks9 of 12 passed
Key figures · 110
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥126m | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥162m | 2021-01-01 → 2021-12-31 | Standalone | Net sales |
| Revenue | ¥199m | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥276m | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.0bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥743m | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | −¥864m | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | −¥754m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥866m | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥887m | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥745m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥729m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥786m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥787m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥141m | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥141m | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥759m | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥909m | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income (owners) | −¥915m | 2021-01-01 → 2021-12-31 | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥784m | 2020-01-01 → 2020-12-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥782m | 2019-01-01 → 2019-12-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥130m | 2018-01-01 → 2018-12-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥760m | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥913m | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | −¥768m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥783m | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥130m | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.5bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥1.4bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥1.4bn | at 2021-12-31 | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥366m | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥364m | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.2bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2021-12-31 | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.3bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.4bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.4bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.4bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥847m | at 2021-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2022-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥847m | at 2021-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥931m | at 2021-12-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.5bn | at 2020-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.1bn | at 2019-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.1bn | at 2018-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥718m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥817m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥701m | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥578m | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥307m | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥62m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥110m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13m | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥133m | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1m | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥882m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥397m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥721m | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥25m | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-36.31 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-53.18 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-53.08 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-55.31 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-54.19 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-66.6 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-66.68 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.35 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.38 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥11.27 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥11.3 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥47.26 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥56.44 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥57.43 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥93.85 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥95.7 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥102.24 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥103.88 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥121.19 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥122.78 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 74.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.0% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.2% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.5% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.1% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.3% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.3% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.8% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 24,422,619 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,759,419 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,008,319 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,981,819 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,459,419 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 30 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 44 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 40 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 40 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 39 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 21
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥190m |
| Cell Sheet Regenerative Medicinereportable segment | employees | at 2022-12-31 | 19 pure |
| Cell Sheet Regenerative Medicinereportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥10m |
| Cell Sheet Regenerative Medicinereportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥10m |
| Cell Sheet Regenerative Medicinereportable segment | segment assets | at 2022-12-31 | ¥82m |
| Cell Sheet Regenerative Medicinereportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥463m |
| Laboratory Consumables And Equipmentreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥563,000 |
| Laboratory Consumables And Equipmentreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥8m |
| Laboratory Consumables And Equipmentreportable segment | employees | at 2022-12-31 | 7 pure |
| Laboratory Consumables And Equipmentreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥116m |
| Laboratory Consumables And Equipmentreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥116m |
| Laboratory Consumables And Equipmentreportable segment | segment assets | at 2022-12-31 | ¥196m |
| Laboratory Consumables And Equipmentreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥90m |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥563,000 |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥8m |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥126m |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥126m |
| —segment total | segment assets | at 2022-12-31 | ¥277m |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | −¥553m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 895
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)けやき監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)吉 村 潤 一 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)宮 下 圭 二 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)（細胞培養器材事業に関する固定資産の減損） | |
| Description including reason kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Auditors response kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior4YearDuration | 1026094000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 275824000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | 199466000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 161673000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration | － | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | 140675000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | -786234000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | -744701000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -887171000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | － | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | 129745000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | -782398000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | -783860000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -914546000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | － | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | 120431000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | -786283000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | -776732000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -900806000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | － | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 1411784000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | 1345795000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant | 1526373000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 1027132000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | － | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 1586503000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 1456242000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant | 1806457000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 1392185000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | － | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 121.19 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 102.24 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 93.85 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 56.44 | |
| Net assets per share (5-year summary) | CurrentYearInstant | － | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 11.35 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | -66.60 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | -55.31 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -53.18 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 9 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | mismatch |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | mismatch |
| statement vs summary · total assets | pass |